These in vitro studies indicate NF-κB, AMPK, PI3K/AKT, and chemokine (motif C-C) ligand (CCL)-2/CC chemokine receptor (CCR)-2, may become key targets for the regulation of macrophages by CM in the treatment of CHD. The gene discussed is CCL2; the disease is coronary artery disorder.